References
- Lode H., Stahlmann R. Evaluation of safety and tolerance in clinical trials with antimicrobials agent. Eur. J. Clin. Microbiol. Infect. Dis. 1990; 9: 530–533
- Shepherd G. M. Allergy to β lactams antibiotics. Immunol. Allergy Clin. North Am. 1991; 11: 611
- Asero R. Detection of patients with multiple drug allergy syndrome by elective tolerance test. Ann. Allergy Asthma Immunol. 1998; 80: 185–189
- Nettis E., Colanardi M. C., Di Paola R., Ferrannini A., Tursi A. Tolerance test in patients with multiple drug allergy syndrome. Immunopharmacol. Immunotoxicol. 2001; 23: 617–626
- Naldi L., Conforti A., Venegoni M., Troncon M. G., Caputi A., Ghiotto E., Cocci A., Moretti U., Velo G., Leone R. Cutaneneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br. J. Clin. Pharmacol. 1999; 48: 839–846
- Van der Linden P. D., van der Lei J., Vlug A. E., Stricker B. H. Skin reactions to antibacterial agents in general practice. J. Clin. Epidemiol. 1998; 51: 703–708
- Periti P., Mazzei T., Mini E., Novelli A. Adverse effects of macrolide antibacterials. Drug Saf. 1993; 9: 346–364
- Walsh J. H., Peterson W. L. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N. Engl. J. Med. 1995; 333: 984–991
- Peterson J. G., McColl K. E.L. Eradication of Helicobacter pylori: an objective assessment of current therapies. Br. J. Clin. Pharmacol. 1997; 43: 223–243
- Jaffe A., Bush A. Anti‐inflammatory effects of macrolides in lung disease. Pediatr. Pulmonol. 2001; 31: 464–273
- Spahn J. D., Fost D. A., Covar R., Martin R. J., Brown E. E., Szefler S. J., Leung D. Y. Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study. Ann. Allergy Asthma Immunol. 2001; 87: 501–505
- Yu K. W., Briones F., Chin N. X., Neu H. C. Antibacterial activity of rokitamycin compared with that of other macrolides. Diagn. Microbiol. Infect. Dis. 1991; 14: 331–335
- Bryskier A., Labro M. T. Macrolides. New therapeutic prospects. Presse Med. 1994; 23: 1762–1766
- Morohoshi T., Tanini T., Nishino T. Bacteriological evaluation of a new macrolide antibiotic TMS‐19‐19‐Q (3‐O‐propionyl‐leucomycin A5). Chemotherapy 1984; 32: 12–25
- Cinco M., Padovan D., Stinco G., Trevisan G. In vitro activity of rokitamycin, a new macrolide, against Borrelia burgdoferi. Antimicrob. Agents Chemoter. 1995; 39: 1185–1186
- Morishita M., Suzuki T., Sakai A., Endo S., Watanabe M., Nagata A., Ishioka T. Studies on absorption, metabolism and excretion of TMS‐19‐Q in humans. J. Chemother. 1984; 32: 99–115
- Goto S., Tsuji A., Ogawa M., Yokoyama S., Sagai H., Toriya M., Morohoshi T., Hayano K. Bacteriological evaluations of the metabolites of TMS‐19‐Q, a new macrolide antibiotic. J. Chemother. 1984; 32: 37–45
- Cazzola M., Matera M. G., Paterno E., Scaglione F., Santangelo G., Rossi F. Impact of rokitamycin, a new 16‐membered macrolide, on serum theophylline. J. Chemother. 1991; 3: 240–244
- Morishita M., Suzuki T., Hayano K. The in vivo pharmacokinetics of rokitamycin: a new macrolide antibiotic. Chemother. Field 1987; 3: 381–390
- Morishita M., Ohno M., Serizawa K., Fujiwara T., Sakakibara H. Isolation and identification of metabolites of TMS‐19‐Q. J. Chemother. 1984; 32: 85–92
- Slater J. E. Hypersensitivity to macrolide antibiotics. Ann. Allergy 1991; 66: 193–195
- Demoly P., Benahmed S., Valembois H., Sahla H., Messaad D., Goodard P. H., Michel F. B., Bousquet J. L'allergie aux macrolides. Revue de la littérature. Press. Med. 2000; 29: 321–326
- Kawauchi K., Sato Y., Kimura S., Yonesaka S., Yokoyama M., Onishi A., Asuka T., Okamoto T., Takebe Y., Tsushima T. Clinical results of a rokitamycin dry syrup in pediatric infections. J.P.N. J. Antibiot. 1998; 41: 673–685
- Gallardo M. A., Thomas I. Hypersensitivity reaction to erythromycin. Cutis 1999; 64: 374–376
- Kruppa A., Scharffetter‐Kochanek K., Krieg T., Hunzelmann N. Immediate reaction to roxithromycin and prick test cross‐sensitization to rythromycin and clarithromycin. Dermatology 1998; 196: 335–336
- Tonnesen M. G., Harrist T. J., Wintroub B. V., Mihm M. C., Jr., Soter N. A. Erythema multiforme: microvascular damage and infiltration of lymphocytes and basophils. J. Invest. Dermatol. 1983; 80: 282–286
- Correia O., Delgado L., Ramos J. P., Resende C., Torrinha J. A. Cutaneous T‐cell recruitment in toxic epidermal necrolysis: further evidence of CD8+ lymphocyte involvement. Arch. Dermatol. 1993; 129: 466–468
- Smith J. W., Johnson J. E., Cuff L. E. Studies on the epidemiology of adverse drug reactions. An evaluation of penicillin allergy. N. Eng. J. Med. 1966; 274: 998–1002
- Riario‐Sforza G., Zara C., Incorvaia C. Atopy as a risk factor in drug allergy: a prospective study [abstract]. Allergy 1996; 51: 74
- Pastorello E. A., Zara C., Riario‐Sforza G., Pravettoni V., Incorvaia C. Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti‐inflammatory. Allergy 1998; 53: 880–884
- Quiralte J., Blanco C., Castillo R., Delgado J., Carrillo T. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J. Allergy Clin. Immunol. 1996; 98: 678–685
- Sullivan T. J., Ong R. C., Gilliam L. K. Studies of the multiple drug allergy syndrome. [abstract]. J. Allergy Clin. Immunol. 1989; 83: 270